AQT90 FLEX D-dimer Clinical Sensitivity and Specificity

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRadiometer Medical ApS

About this trial

The goal of this study is evaluate the clinical performance of the AQT90 FLEX D-dimer Test as an aid in the diagnosis of Venous Thromboembolism.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject is 18 years of age and older

Subject, who presents with signs and symptoms of VTE and had low or moderate pre-test probability of DVT or PE assessed by Well's score

Subject must be able to understand information given, and be willing and able to voluntarily give their consent to participate in this study

Disqualifiers

Subject, who is pregnant

Subject, who has received fibrinolytic therapy within the previous seven days

Subject, who has received treatment with anticoagulants (unfractionated heparin, LMWH, VKA (vitamin K-antagonists), DOACs (direct oral anticoagulants) within the previous seven days

Subject, who has had trauma or surgery within the previous four weeks

Trial population

The study population will consist of adult patients presenting with signs and symptoms of VTE and getting clinical evaluation of the pretest probability of VTE scored as low or moderate corresponding to a Well's score between 0-2 for DVT and between 0-6 for PE.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • D-dimer test

    Diagnostic test

    Blood sample collection for D-dimer testing

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Sensitivity and Specificity

Clinical performance (clinical sensitivity, clinical specificity, Negative Predictive Values (NPV), Positive Predictive Values (PPV), Positive Likelihood Ratio (LR+), Negative Likelihood Ratio (LR-) and 95 % confidence intervals) for the AQT90 FLEX D-dimer assay against the hospital diagnosis.

Time frame
From enrollment to blood sample collection; ~1 hour

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.